Skip to main content
. 2018 Jul 28;25:59. doi: 10.1186/s12929-018-0460-2

Fig. 2.

Fig. 2

Cumulative incidence of HBeAg loss and seroconversion in the patients with CHB by (a) CLEC18 and (b) HBsAg levels. Curves of cumulative rates of HBeAg loss and HBeAg seroconversion derived from Kaplan-Meier analysis stratified by (a) baseline plasma CLEC18 levels and (b) baseline HBsAg levels. Differences between cumulative incidence curves were tested using the log-rank test